GO
Loading...

Lightning Round: Amgen, UPS, NYMEX and More

Friday, 18 Jan 2008 | 7:00 PM ET


Mercado Libre : “The highest growth stock I know.” Cramer would buy MELI because it doesn’t trade off the Fed.

Applied Materials : It might look like it has bottomed, but Cramer urged caution. He doesn’t want to look at AMAT until 2009 when he thinks its solar business will ignite.

Tyco : Don’t buy Tyco, Cramer said.

Amgen : Now Cramer’s least favorite biotech on increased competition and news of government investigations.

Lightning Round
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.

United Parcel Service : Cramer would buy it on a scale on the way down. Wait until it hits $65 before pulling the trigger, he advised.

Cypress Semi : The conventional wisdom seems to be that SunPower , which CY is heavily invested in, is yesterday’s news. Not so, said Cramer. He would buy CY before it reports next week.

Limelight Networks : Be careful in this space, Cramer warned.

Inverness Medical : Cramer scaled out of Inverness to a core position in his charitable trust because it’s a high-multiple stock that isn’t usually favored in this environment. He would buy it back again below $50.

NYMEX Holdings : Time to take profits. People are waiting for a takeover that looks less and less likely, according to Cramer.

Transocean : Because Schlumberger is in a rough patch, RIG could get hurt. But it’s still a stock that can be owned here, Cramer said.


Jim's charitable trust owns Transocean and Inverness Medical.

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

  Price   Change %Change
AMAT
---
AMGN
---
CY
---
IMX
---
LLNW
---
MELI
---
RIG
---
SLB
---
TYC
---
UPS
---

Featured

Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.